PO

POMDOCTOR LIMITED American Depositary Shares

POM · NASDAQ · Healthcare / Pharmaceutical Retailers

1.62USD-0.04 (-2.41%)

Price History

Full chart

Market Stats

Previous Close1.66
Open1.62
Day Range1.58 – 1.62
52-Week Range0.0643 – 6.43
Volume6.17K
Market Cap9.64M
P/E (TTM)0.00
Forward P/E0.00
EPS-6.05
Dividend Yield0.00%
50-Day Avg0.857
200-Day Avg4.50

About

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Zhenyang Shi
  • Employees165
  • HeadquartersYongxu Industrial Park, Guangzhou, China, 510000, USA
  • Websitehttps://www.7lk.com

Leadership

  • Mr. Zhenyang ShiCo-Founder, CEO & Chairman · b. 1978
  • Ms. Li XuCo-Founder & CFO · b. 1975
  • Mr. Guoji LuoVP & Director · b. 1985

Financials

Income Statement

Currency: CNY2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.25B7.22B8.06B8.36B9.37B10.70B9.26B7.04B5.92B5.08B4.67B4.88B5.02B31.36B33.53B35.98B34.44B141.21M215.38M245.22M304.85M342.56M399.91M
Growth (%)-+476.30%+11.69%+3.68%+12.01%+14.24%-13.47%-23.98%-15.90%-14.17%-8.17%+4.54%+2.97%+524.33%+6.92%+7.32%-4.30%-99.59%+52.53%+13.85%+24.32%+12.37%+16.74%
Cost of Revenue12.00M637.00M712.00M649.00M606.00M718.00M403.00M127.00M172.00M170.00M146.00M207.00M175.00M12.64B14.04B16.67B15.50B87.48M162.88M190.36M266.13M294.86M347.63M
Gross Profit1.24B6.58B7.35B7.71B8.76B9.98B8.86B6.91B5.75B4.91B4.52B4.67B4.85B18.72B19.50B19.32B18.94B53.72M52.51M54.86M38.72M47.69M52.28M
Gross Margin99.04%91.18%91.17%92.24%93.53%93.29%95.65%98.20%97.09%96.65%96.87%95.76%96.52%59.69%58.14%53.68%55.00%38.05%24.38%22.37%12.70%13.92%13.07%
Operating Expense1.12B5.81B6.45B7.02B7.95B9.21B8.16B6.75B5.11B4.24B3.85B4.07B4.17B15.61B15.24B15.42B14.57B294.14M132.18M58.46M60.97M73.49M168.66M
Operating Income125.00M775.00M905.00M693.00M806.00M768.00M695.00M160.00M637.00M670.00M668.00M604.00M673.00M3.11B4.26B3.90B4.37B-240.42M-79.67M-3.59M-22.25M-25.79M-116.37M
Operating Margin9.98%10.73%11.22%8.29%8.61%7.18%7.51%2.27%10.76%13.19%14.32%12.38%13.40%9.92%12.70%10.83%12.70%-170.26%-36.99%-1.47%-7.30%-7.53%-29.10%
EBITDA163.00M812.00M969.00M750.00M862.00M798.00M715.00M291.00M966.00M1.22B854.00M1.20B1.39B8.97B9.52B8.02B5.12B-221.54M-58.58M-3.81M-22.99M-24.27M-117.90M
EBITDA Margin13.01%11.24%12.01%8.97%9.20%7.46%7.72%4.13%16.32%24.03%18.30%24.58%27.65%28.59%28.39%22.28%14.87%-156.89%-27.20%-1.55%-7.54%-7.08%-29.48%
Net Income53.00M258.00M371.00M248.00M334.00M300.00M235.00M53.00M257.00M285.00M-212.00M242.00M327.00M1.13B2.69B398.00M3.03B-256.44M-188.40M-125.51M-145.39M-143.36M-212.58M
Net Income Margin4.23%3.57%4.60%2.97%3.57%2.80%2.54%0.75%4.34%5.61%-4.54%4.96%6.51%3.62%8.03%1.11%8.79%-181.61%-87.47%-51.18%-47.69%-41.85%-53.16%
R&D-----------------1.99M4.28M3.59M3.37M3.00M12.86M
R&D as % of Total Revenue-----------------1.41%1.99%1.46%1.11%0.88%3.22%
Interest Expense37.00M373.00M337.00M339.00M339.00M330.00M370.00M65.00M254.00M265.00M273.00M268.00M280.00M1.50B1.52B1.53B1.59B14.00M16.29M16.02M13.85M12.96M12.89M
Interest Expense % of Total Revenue2.95%5.17%4.18%4.05%3.62%3.08%4.00%0.92%4.29%5.22%5.85%5.49%5.57%4.77%4.55%4.25%4.62%9.91%7.56%6.53%4.54%3.78%3.22%

Balance Sheet

Currency: CNY2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets13.43B13.35B14.02B14.24B15.11B16.48B15.78B2.88B14.91B15.78B14.85B15.67B16.33B114.90B116.70B119.67B6.75B77.47M19.31M48.62M66.31M46.23M107.56M
Total Liabilities5.37B5.07B4.84B4.37B4.73B5.38B4.95B2.17B10.57B11.33B10.53B11.35B11.91B89.07B86.84B88.90B3.48B386.82M1.80B1.95B2.03B2.14B588.85M
Total Equity8.06B8.28B9.18B9.88B10.38B11.10B10.83B703.00M4.34B4.45B4.32B4.32B4.41B25.84B29.86B30.76B3.27B-309.35M-1.85B-1.97B-2.12B-2.26B-453.97M
Cash100.00M29.00M121.00M48.00M55.00M384.00M46.00M4.00M109.00M25.00M23.00M14.00M25.00M635.00M898.00M1.35B163.00M12.28M2.17M2.49M6.72M7.65M9.58M
Total Debt1.80B1.67B312.00M698.00M576.00M930.00M1.06B668.00M3.80B3.66B4.06B4.45B4.95B34.01B34.26B35.42B674.00M114.44M341.26M361.24M413.29M441.10M454.94M
Net Debt1.70B1.64B191.00M650.00M521.00M546.00M1.01B664.00M3.69B3.63B4.04B4.44B4.92B33.37B33.37B34.08B511.00M102.16M339.09M358.76M406.58M433.45M445.36M

Cash Flow

Currency: CNY2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow166.00M57.00M34.00M68.00M127.00M131.00M44.00M59.00M686.00M592.00M497.00M854.00M939.00M8.45B7.48B8.64B85.00M-34.80M-15.68M-22.02M-45.80M-16.13M-148.48M
Investing Cash Flow-98.00M-------157.00M-747.00M-969.00M-411.00M-1.23B-1.16B-15.50B-7.93B-7.83B8.00M25.00K-500.00K--111.89K-33.37K-1.61M
Financing Cash Flow-173.00M-35.00M-86.00M-15.00M163.00M38.00M-15.00M95.00M149.00M293.00M-88.00M363.00M233.00M1.19B717.00M-219.00M-8.00M36.39M5.44M22.49M50.07M17.02M153.93M
Capital Expenditure98.00M000000156.00M941.00M1.22B1.31B1.22B1.23B8.55B7.58B7.59B0000111.89K37.77K1.01M
Free Cash Flow68.00M57.00M34.00M68.00M127.00M131.00M44.00M-97.00M-255.00M-624.00M-813.00M-369.00M-291.00M-108.00M-104.00M1.05B85.00M-34.80M-15.68M-22.02M-45.91M-16.17M-149.49M
FCF to OCF40.96%100.00%100.00%100.00%100.00%100.00%100.00%-164.41%-37.17%-105.41%-163.58%-43.21%-30.99%-1.28%-1.39%12.15%100.00%100.00%100.00%100.00%100.24%100.23%100.68%

Earnings

Report DateMar 31, 2025Dec 3, 2025
EPS Estimate0.000.00
EPS Actual-1.49-1.91
Surprise--
Timing--

Key Statistics & Ratios

Market Cap9.64M
Enterprise Value74.86M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.02
Price / Book0.00
EPS-6.05
Book Value-8.77
Revenue (TTM)399.91M
Gross Profit (TTM)52.28M
EBITDA-116.38M
Profit Margin-53.16%
Operating Margin-46.62%
Return on Equity0.00%
Return on Assets-94.72%
Shares Outstanding8.59M
Shares Float3.46M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
0.31%
Insiders
0.00%
Retail / Other
99.69%

Top Institutional Holders

  • Citadel Advisors Llc
    21.27K0.28%
  • XTX Topco Ltd
    187.44K0.13%
  • TWO SIGMA SECURITIES, LLC
    152.84K0.11%
  • Susquehanna International Group, LLP
    59.08K0.04%
  • Caitong International Asset Management Co., Limited.
    31.59K0.02%
  • Virtu Financial LLC
    17.56K0.01%
  • UBS Group AG
    16.64K0.01%
  • SRS Capital Advisors Inc
    7220.01%
  • Steward Partners Investment Advisory, LLC
    2.00K0.00%
  • Rhumbline Advisers
    7500.00%
  • Ground Swell Capital, LLC
    00.00%
  • Millennium Management LLC
    00.00%
  • Scientech Research LLC
    00.00%
  • StoneX Group Inc
    00.00%
  • HRT FINANCIAL LLC
    00.00%

Stock Splits

  • Jun 22, 20261:18